U.S., Jan. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07315542) titled 'Diagnostic and Therapeutic Targets in Cartilaginous Tumours' on Dec. 18, 2025.
Brief Summary: This study, "Finding new diagnostic and therapeutic targets in cartilaginous tumours," focuses on improving the diagnosis, prognostic stratification, and treatment options for chondroid tumours, particularly chondrosarcoma. Chondrosarcoma is the most common primary malignant bone tumour in adults and is characterized by resistance to chemotherapy and radiotherapy, making accurate diagnosis and optimal surgical management critical. Distinguishing benign cartilage tumours (enchondromas, atypical cartilaginous tumours) from low-grade chondrosar...